These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7809382)

  • 1. Effects of acute exercise on the changes of lipid profiles and peroxides, prostanoids, and platelet activation in hypercholesterolemic patients before and after treatment.
    Chen MF; Hsu HC; Lee YT
    Prostaglandins; 1994 Sep; 48(3):157-74. PubMed ID: 7809382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise shifts the platelet aggregation modulatory role from native to mildly oxidized low-density lipoprotein.
    Hsu HC; Lee YT; Chen MF
    Med Sci Sports Exerc; 2000 May; 32(5):933-9. PubMed ID: 10795783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
    Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholesterol-lowering therapy on pressor hyperreactivity to stress in hypercholesterolemic patients.
    Minami M; Atarashi K; Ishiyama A; Hirata Y; Goto A; Omata M
    Hypertens Res; 2003 Apr; 26(4):273-80. PubMed ID: 12733694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults.
    Janatuinen T; Laaksonen R; Vesalainen R; Raitakari O; Lehtimäki T; Nuutila P; Knuuti J
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):561-8. PubMed ID: 11588526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
    Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
    Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
    Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
    Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.
    Tamura A; Watanabe T; Nasu M
    Circ J; 2003 Oct; 67(10):816-20. PubMed ID: 14578611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia.
    Bröijersén A; Eriksson M; Larsson PT; Beck O; Berglund L; Angelin B; Hjemdahl P
    Eur J Clin Invest; 1994 Jul; 24(7):488-98. PubMed ID: 7957507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo- and hypercholesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components.
    Oubiña P; Sánchez-Muniz FJ; Ródenas S; Cuesta C
    Br J Nutr; 2001 Jan; 85(1):41-7. PubMed ID: 11227032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin.
    Porreca E; Di Febbo C; Baccante G; Di Nisio M; Cuccurullo F
    J Am Coll Cardiol; 2002 Jun; 39(11):1752-7. PubMed ID: 12039487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
    Hoffman R; Brook GJ; Aviram M
    Atherosclerosis; 1992 Mar; 93(1-2):105-13. PubMed ID: 1596293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
    Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
    Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes.
    Gragnoli G; Signorini AM; Tanganelli I
    Acta Endocrinol (Copenh); 1985 May; 109(1):104-7. PubMed ID: 2408435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.